Figure 2From: Hepatic steatosis in patients with HIV-Hepatitis C Virus coinfection: is it associated with antiretroviral therapy and more advanced hepatic fibrosis?Prevalence of hepatic steatosis (in percentage) depending on type of therapy received. Number of patients with steatosis in the 4 groups was as follows: Sequential 9/11, NRTI 7/10, No therapy 10/17 and HAART only 9/22. HAART only vs NRTIs only, p = 0.11. HAART only vs sequential therapy, p = 0.064.Back to article page